Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Miners

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Clinical Pharmacokinetics|November 1, 1989
Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acidJ O Miners
British Journal of Clinical Pharmacology|April 24, 1999
Cytochrome P450 isoform selectivity in human hepatic theobromine metabolismS Gates, J O Miners
Biochemical Pharmacology|October 1, 1984
The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformationR Drew, J O Miners
British Journal of Clinical Pharmacology|December 12, 2001
The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomesK Bowalgaha, J O Miners
Journal of Chromatography|May 9, 1980
Simple, rapid procedure for the determination of valproate and ethosuximide in plasma by gas-liquid chromatographyN Grgurinovich, J O Miners
Pharmacogenetics|February 1, 1993
The misuse of urinary metabolite excretion data in drug metabolism studiesJ O Miners, D J Birkett
Pharmacology & Therapeutics|January 1, 1991
Drug glucuronidation in humansJ O Miners, P I Mackenzie
British Journal of Clinical Pharmacology|July 15, 1998
Cytochrome P4502C9: an enzyme of major importance in human drug metabolismJ O Miners, D J Birkett
General Pharmacology|March 1, 1996
The use of caffeine as a metabolic probe for human drug metabolizing enzymesJ O Miners, D J Birkett
British Journal of Clinical Pharmacology|April 1, 1991
Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports eventsD J Birkett, J O Miners
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Clinical Pharmacokinetics|November 1, 1989
Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acidJ O Miners
British Journal of Clinical Pharmacology|April 24, 1999
Cytochrome P450 isoform selectivity in human hepatic theobromine metabolismS Gates, J O Miners
Biochemical Pharmacology|October 1, 1984
The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformationR Drew, J O Miners
British Journal of Clinical Pharmacology|December 12, 2001
The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomesK Bowalgaha, J O Miners
Journal of Chromatography|May 9, 1980
Simple, rapid procedure for the determination of valproate and ethosuximide in plasma by gas-liquid chromatographyN Grgurinovich, J O Miners
Pharmacogenetics|February 1, 1993
The misuse of urinary metabolite excretion data in drug metabolism studiesJ O Miners, D J Birkett
Pharmacology & Therapeutics|January 1, 1991
Drug glucuronidation in humansJ O Miners, P I Mackenzie
British Journal of Clinical Pharmacology|July 15, 1998
Cytochrome P4502C9: an enzyme of major importance in human drug metabolismJ O Miners, D J Birkett
General Pharmacology|March 1, 1996
The use of caffeine as a metabolic probe for human drug metabolizing enzymesJ O Miners, D J Birkett
British Journal of Clinical Pharmacology|April 1, 1991
Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports eventsD J Birkett, J O Miners
Pageof 14